Skip to main content

Table 5 The correlation between clinical outcome and patient's characteristics

From: Multi-drug resistance 1 genetic polymorphism and prediction of chemotherapy response in Hodgkin's Lymphoma

Baseline Factors

Complete Remission

N (%)

Relapsed Disease

N (%)

Total

P-value

Age at diagnosis

    

< 30

43 (44.8)

19 (55.9)

62

0.266

≥ 30

53 (55.2)

15 (44.1)

68

 

Gender

    

Males

50 (52.1)

21 (61.8)

71

0.330

Females

46 (47.9)

13 (38.2)

59

 

Histology

    

NSa

46 (64.8)

16 (72.7)

62

0.490

MCb

25 (35.2)

6 (27.3)

31

 

Stage

    

Early stages (I &II)

41 (51.9)

20 (62.5)

61

0.309

Advanced stages (III & IV)

38 (48.1)

12 (37.5)

50

 

Presence of B-symptoms

    

Yes

54 (63.5)

19 (59.4)

73

0.679

No

31 (36.5)

13 (40.6)

44

 
  1. aNodular sclerosis; bMixed cellularity.